Aditxt (ADTX) Non-Current Assets (2019 - 2026)
Aditxt (ADTX) recorded quarterly Non-Current Assets of $13.1 million in Q1 2026, up 2.85% quarter-over-quarter from $12.7 million in Q4 2025, and down 56.48% on a YoY basis from $30.0 million in Q1 2025.
Aditxt (ADTX) Non-Current Assets (2019 - 2026) Analysis & Trends
Aditxt's Non-Current Assets history runs 8 years deep, the most recent figure standing at $13.1 million for Q1 2026.
- In Q1 2026, Non-Current Assets fell 56.48% year-over-year to $13.1 million; the TTM figure through Mar 2026 stood at $69.4 million (down 39.54% YoY), while the FY2025 annual figure was $12.7 million, down 57.89% from the prior year.
- Non-Current Assets was $13.1 million for Q1 2026 at Aditxt, up from $12.7 million in the prior quarter.
- In the past five years, Non-Current Assets ranged from a high of $37.7 million in Q4 2023 to a low of $4.8 million in Q3 2023.
- Historically, Non-Current Assets has averaged $17.1 million across 5 years, with a median of $12.7 million in 2025.
- The sharpest annual moves came in 2023 and 2025: Non-Current Assets jumped 528.63% in 2023, then tumbled 59.0% in 2025.
- A 5-year view of Non-Current Assets shows it stood at $6.0 million in 2022, then surged by 528.63% to $37.7 million in 2023, then fell by 19.97% to $30.1 million in 2024, then slumped by 57.89% to $12.7 million in 2025, then rose by 2.85% to $13.1 million in 2026.
- The last three Non-Current Assets figures came in at $13.1 million (Q1 2026), $12.7 million (Q4 2025), and $11.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 62,953.78 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 289.41 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 4.56 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 486.60 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 30.30 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 5.18 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 14.75 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 39.71 Mn |
| 10 | Aditxt | 2,485.68 | -2.16 Mn | 2,868.00 | 13.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13.06 Mn |
| Dec 31, 2025 | 12.70 Mn |
| Sep 30, 2025 | 11.38 Mn |
| Jun 30, 2025 | 32.26 Mn |
| Mar 31, 2025 | 30.00 Mn |
| Dec 31, 2024 | 30.14 Mn |
| Sep 30, 2024 | 27.75 Mn |
| Jun 30, 2024 | 26.87 Mn |
| Mar 31, 2024 | 26.38 Mn |
| Dec 31, 2023 | 37.67 Mn |
| Sep 30, 2023 | 4.80 Mn |
| Jun 30, 2023 | 5.15 Mn |
| Mar 31, 2023 | 5.69 Mn |
| Dec 31, 2022 | 5.99 Mn |
| Sep 30, 2022 | 6.56 Mn |
| Jun 30, 2022 | 7.10 Mn |
| Mar 31, 2022 | 7.35 Mn |
| Dec 31, 2021 | 7.25 Mn |
| Sep 30, 2021 | 7.20 Mn |
| Jun 30, 2021 | 5.98 Mn |